Literature DB >> 11762263

Anxiety, delirium, and pain in the intensive care unit.

J W Szokol1, J S Vender.   

Abstract

Anxiety, agitation, delirium, and pain are common findings in the ICU. These unhealthy states may lead to increased irritability, discomfort, hypertension, tachycardia, cardiac ischemia, harmful motor activity, and psychologic disquiet for the patient. The appropriate treatment of these conditions may lead to decreased morbidity and mortality in the critically ill patient. Unfortunately, the management of anxiety, agitation, delirium, and pain in the intensive care unit is not ideal. Many patients interviewed after an ICU stay rate their pain control as poor and their memories of their stay as unpleasant. Furthermore, many caregivers lack sufficient understanding of the appropriate or indicated uses of drugs to allay patients' fears and pain. The use of suitable protocols for the proper titration of sedation of mechanically ventilated patients and monitoring of the level of sedation in ventilated patients may decrease the amount of time that patients are ventilated and may alleviate some of the emotional stresses of recall of painful procedures or uncomfortable mechanical ventilation. Future research into protocols for the care of the critically ill patient can enhance the overall well-being of these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11762263     DOI: 10.1016/s0749-0704(05)70182-2

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  9 in total

Review 1.  Research issues in the evaluation of cognitive impairment in intensive care unit survivors.

Authors:  James C Jackson; Sharon M Gordon; E Wesley Ely; Candice Burger; Ramona O Hopkins
Journal:  Intensive Care Med       Date:  2004-09-15       Impact factor: 17.440

2.  Postoperative Delirium in Lung Cancer Anatomical Resection-Analysis of Risk Factors and Prognosis.

Authors:  Hironori Ishibashi; Ryo Wakejima; Ayaka Asakawa; Yusuke Sugita; Yuya Ishikawa; Mariko Hanafusa; Shunichi Baba; Yasuhiro Nakashima; Katsutoshi Seto; Kenichi Okubo
Journal:  World J Surg       Date:  2022-01-13       Impact factor: 3.352

3.  Patients' memory and psychological distress after ICU stay compared with expectations of the relatives.

Authors:  Hilde Myhren; Kirsti Tøien; Oivind Ekeberg; Susanne Karlsson; Leiv Sandvik; Olav Stokland
Journal:  Intensive Care Med       Date:  2009-09-15       Impact factor: 17.440

4.  Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes.

Authors:  Jeffery C Woods; Lorraine C Mion; Jason T Connor; Florence Viray; Lisa Jahan; Cecilia Huber; Renee McHugh; Jeffrey P Gonzales; James K Stoller; Alejandro C Arroliga
Journal:  Intensive Care Med       Date:  2004-02-14       Impact factor: 17.440

Review 5.  The septic brain.

Authors:  Emilio L Streck; Clarissa M Comim; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

6.  Research in critically ill patients: standards of informed consent.

Authors:  Catherine Chenaud; Paolo Merlani; Bara Ricou
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

7.  Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients.

Authors:  Mohammad Taghi Beigmohammadi; Majid Hanifeh; Mohammad Reza Rouini; Behjat Sheikholeslami; Mojtaba Mojtahedzadeh
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

8.  Community Consultation for Planned Emergent Use Research: Experiences From an Academic Medical Center.

Authors:  Nathan J Smischney; Jasleen Pannu; Richard F Hinds; Jennifer B McCormick
Journal:  JMIR Res Protoc       Date:  2018-05-02

Review 9.  Clinical identification of cognitive impairment in ICU survivors: insights for intensivists.

Authors:  Sharon M Gordon; James C Jackson; E Wesley Ely; Candace Burger; Ramona O Hopkins
Journal:  Intensive Care Med       Date:  2004-10-02       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.